Screen-detected multiple primary lung cancers in the ITALUNG trial
- PMID: 29607181
- PMCID: PMC5864678
- DOI: 10.21037/jtd.2018.01.95
Screen-detected multiple primary lung cancers in the ITALUNG trial
Abstract
Occurrence of multiple primary lung cancers (MPLC) in individuals undergoing low-dose computed tomography (LDCT) screening has not been thoroughly addressed. We investigated MPLC in subjects recruited in the ITALUNG randomized clinical trial. Cases of cytologically/histologically proven MPLC detected at screening LDCT or follow-up CT were selected and pathologically re-evaluated according to the WHO 2015 classification. Overall 16 MPLC were diagnosed at screening LDCT (n=14, all present at baseline) or follow-up CT (n=2) in six subjects (4 in one subject, 3 in two and 2 in three subjects), representing 0.43% of the 1,406 screenees and 15.8% of the 38 subjects with at least one screen-detected primary lung cancer. MPLC included 9 adenocarcinomas in three subjects and a combination of 7 different tumour histotypes in three subjects. MPLC, mostly adenocarcinomas, are not uncommon in smokers and ex-smokers with at least one LDCT screen detected primary lung cancer.
Keywords: Multiple primary lung cancer; adenocarcinoma; low-dose CT screening; lung cancer.
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Figures
References
-
- Picozzi G, Paci E, Lopes-Pegna A, et al. Screening of lung cancer with low-dose spiral CT: results of a three-year pilot study and design of the randomized controlled trial “Italung-CT”. Radiol Med 2005;109:17-26. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources